Gerresheimer AG (ETR:GXI) Receives €79.80 Consensus Target Price from Brokerages
Gerresheimer AG (ETR:GXI) has been given a consensus rating of “Hold” by the nine brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is €79.80 ($93.88).
Several equities research analysts have recently commented on GXI shares. Independent Research GmbH set a €78.00 ($91.76) target price on shares of Gerresheimer AG and gave the stock a “neutral” rating in a research report on Wednesday, July 19th. Berenberg Bank set a €85.00 ($100.00) target price on shares of Gerresheimer AG and gave the stock a “buy” rating in a research report on Wednesday, May 24th. DZ Bank AG reissued a “buy” rating on shares of Gerresheimer AG in a research report on Monday, July 17th. Deutsche Bank AG set a €82.00 ($96.47) target price on shares of Gerresheimer AG and gave the stock a “buy” rating in a research report on Friday, July 7th. Finally, Kepler Capital Markets set a €70.00 ($82.35) target price on shares of Gerresheimer AG and gave the stock a “sell” rating in a research report on Thursday, July 13th.
Shares of Gerresheimer AG (ETR:GXI) traded down 0.162% during trading on Tuesday, hitting €69.188. The stock had a trading volume of 100 shares. The firm has a 50-day moving average of €71.04 and a 200 day moving average of €73.13. Gerresheimer AG has a 1-year low of €64.00 and a 1-year high of €79.47. The company has a market capitalization of €2.17 billion and a P/E ratio of 19.166.
Gerresheimer AG Company Profile
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.